Mc Kinley Carter Wealth Services, Inc. Amgen Inc Transaction History

Mc Kinley Carter Wealth Services, Inc.

  • $1.6 Billion
  • Q4 2024

A detailed history of Mc Kinley Carter Wealth Services, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Mc Kinley Carter Wealth Services, Inc. holds 1,523 shares of AMGN stock, worth $423,211. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,523
Previous 1,518 0.33%
Holding current value
$423,211
Previous $489,000 19.02%
% of portfolio
0.02%
Previous 0.03%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 22, 2025
BUY
$258.78 - $328.31 $1,293 - $1,641
5 Added 0.33%
1,523 $396,000
Q3 2024

Oct 15, 2024
BUY
$309.38 - $337.38 $1,237 - $1,349
4 Added 0.26%
1,518 $489,000
Q2 2024

Aug 09, 2024
BUY
$262.75 - $319.31 $262 - $319
1 Added 0.07%
1,514 $473,000
Q1 2024

Apr 26, 2024
SELL
$268.87 - $324.56 $5,377 - $6,491
-20 Reduced 1.3%
1,513 $430,000
Q4 2023

Feb 07, 2024
SELL
$255.7 - $288.46 $19,688 - $22,211
-77 Reduced 4.78%
1,533 $441,000
Q3 2023

Oct 13, 2023
BUY
$218.65 - $271.46 $9,839 - $12,215
45 Added 2.88%
1,610 $432,000
Q2 2023

Aug 02, 2023
BUY
$214.27 - $253.37 $1,071 - $1,266
5 Added 0.32%
1,565 $347,000
Q1 2023

Apr 24, 2023
BUY
$225.79 - $275.2 $16,031 - $19,539
71 Added 4.77%
1,560 $377,000
Q4 2022

Feb 07, 2023
SELL
$229.03 - $291.01 $60,692 - $77,117
-265 Reduced 15.11%
1,489 $391,000
Q3 2022

Oct 24, 2022
BUY
$224.46 - $253.15 $11,896 - $13,416
53 Added 3.12%
1,754 $395,000
Q2 2022

Jul 15, 2022
BUY
$230.71 - $256.74 $1,153 - $1,283
5 Added 0.29%
1,701 $414,000
Q1 2022

Apr 27, 2022
BUY
$219.27 - $242.57 $28,724 - $31,776
131 Added 8.37%
1,696 $410,000
Q4 2021

Feb 07, 2022
SELL
$198.88 - $227.6 $7,159 - $8,193
-36 Reduced 2.25%
1,565 $352,000
Q3 2021

Nov 03, 2021
BUY
$212.27 - $248.7 $1,273 - $1,492
6 Added 0.38%
1,601 $341,000
Q2 2021

Aug 12, 2021
SELL
$233.58 - $259.14 $42,277 - $46,904
-181 Reduced 10.19%
1,595 $389,000
Q1 2021

Apr 30, 2021
BUY
$221.91 - $258.6 $3,328 - $3,879
15 Added 0.85%
1,776 $441,000
Q4 2020

Feb 16, 2021
BUY
$216.38 - $257.67 $4,760 - $5,668
22 Added 1.27%
1,761 $405,000
Q4 2020

Feb 12, 2021
SELL
$216.38 - $257.67 $211,186 - $251,485
-976 Reduced 35.95%
1,739 $400,000
Q3 2020

Oct 14, 2020
BUY
$234.65 - $260.95 $938 - $1,043
4 Added 0.15%
2,715 $690,000
Q2 2020

Jul 20, 2020
SELL
$197.81 - $242.74 $10,483 - $12,865
-53 Reduced 1.92%
2,711 $639,000
Q1 2020

May 01, 2020
BUY
$182.24 - $241.7 $95,311 - $126,409
523 Added 23.34%
2,764 $560,000
Q4 2019

Jan 23, 2020
BUY
$189.21 - $243.2 $35,193 - $45,235
186 Added 9.05%
2,241 $540,000
Q3 2019

Nov 14, 2019
SELL
$174.11 - $208.62 $25,420 - $30,458
-146 Reduced 6.63%
2,055 $398,000
Q2 2019

Aug 02, 2019
BUY
$166.7 - $195.41 $25,838 - $30,288
155 Added 7.58%
2,201 $406,000
Q1 2019

May 08, 2019
SELL
$180.87 - $203.88 $9,947 - $11,213
-55 Reduced 2.62%
2,046 $389,000
Q4 2018

Feb 13, 2019
BUY
$178.4 - $208.25 $8,563 - $9,996
48 Added 2.34%
2,101 $409,000
Q3 2018

Nov 06, 2018
SELL
$185.29 - $208.89 $48,175 - $54,311
-260 Reduced 11.24%
2,053 $426,000
Q2 2018

Dec 07, 2018
SELL
$166.05 - $186.51 $32,379 - $36,369
-195 Reduced 7.78%
2,313 $427,000
Q1 2018

May 17, 2018
SELL
$169.43 - $198.0 $2,202 - $2,574
-13 Reduced 0.52%
2,508 $428,000
Q4 2017

Jan 31, 2018
SELL
$168.79 - $188.59 $29,369 - $32,814
-174 Reduced 6.46%
2,521 $438,000
Q3 2017

Oct 31, 2017
SELL
$167.29 - $191.0 $2,342 - $2,674
-14 Reduced 0.52%
2,695 $503,000
Q2 2017

Aug 08, 2017
BUY
N/A
2,709
2,709 $467,000

Others Institutions Holding AMGN

# of Institutions
3,084
Shares Held
405M
Call Options Held
7.56M
Put Options Held
7.16M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $149B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Mc Kinley Carter Wealth Services, Inc. Portfolio

Follow Mc Kinley Carter Wealth Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Kinley Carter Wealth Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mc Kinley Carter Wealth Services, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email